Inscripta

Inscripta, Inc. is a gene editing technology company based in Boulder, Colorado, with additional offices in Pleasanton and San Diego, California. Founded in 2015, Inscripta focuses on developing advanced CRISPR enzymes, specifically its MADzymes, which facilitate precision gene editing. The company has created a benchtop platform for scalable digital genome engineering that includes instruments, consumables, software, and assays, all designed for a fully automated workflow. This platform allows for massively parallel, trackable editing of single cells, significantly enhancing the scale and efficiency of gene editing research. By providing access to its MAD7 CRISPR nuclease for research and development purposes, Inscripta aims to empower scientists to overcome existing technical and licensing challenges, enabling a new wave of biological discovery.